{"id":"W2123437999","doi":"10.1158/1078-0432.ccr-10-0822","title":"Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients with Advanced Solid Tumors or Lymphoma","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Tolerability; Medicine; Regimen; Lymphoma; Pharmacokinetics; Maximum tolerated dose; Antagonist; Nausea; Pharmacology; Toxicity; Internal medicine; Adverse effect; Oncology; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00106958,0.0001729284,0.0003897682,0.0001034998,0.0001191788,0.0000202386,0.000276843,0.0002180538,0.00002036515],"category_scores_gemma":[0.0005188333,0.0001217968,0.00009075252,0.0003059912,0.0004472374,0.0000078858,0.0002355987,0.0003247285,0.000003268191],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004826153,"about_ca_system_score_gemma":0.0005441875,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009408067,"about_ca_topic_score_gemma":0.0008739087,"domain_scores_codex":[0.9978147,0.0001887641,0.0005972671,0.000561079,0.0003837736,0.0004543985],"domain_scores_gemma":[0.9986058,0.0001352424,0.000167151,0.0004476935,0.0005079035,0.0001362013],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01285765,0.002835447,0.03187653,0.000216073,0.0002031665,0.00004901558,0.0001797437,0.00009335117,0.7290108,0.00009591207,0.0004526127,0.2221297],"study_design_scores_gemma":[0.06549194,0.02732333,0.3552404,0.0008219541,0.00008931894,0.000006427412,0.001307364,0.0009860815,0.5354276,0.0004286968,0.01156794,0.001308985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998203,0.000705247,0.00004774792,0.00006385927,0.0002139174,0.0006164248,0.00003824344,0.00000735185,0.0001041856],"genre_scores_gemma":[0.9973937,0.0012805,0.0004413991,0.00006288625,0.0002027221,0.0001230504,0.00006195917,0.00003269509,0.0004010382],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3233639,"threshold_uncertainty_score":0.4966729,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1277390090834309,"score_gpt":0.4825296105298467,"score_spread":0.3547906014464158,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}